Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer Without Egfr Activating Mutations When Other Treatment Options Are Not Considered Suitable

Living with Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer Without Egfr Activating Mutations When Other Treatment Options Are Not Considered Suitable means managing a challenging set of symptoms. This page lists medicine types such as Erlotinib that may be part of a wider care strategy. Products containing Erlotinib feature in this group.